{"title":"VLM-Based Mesh Segmentation Framework for DDH Robotic Ultrasound.","authors":"Yuanbo Wang, Jianwei Cui","doi":"10.3390/bioengineering13101213","DOIUrl":null,"url":null,"abstract":"<p><p>For robotic ultrasound targeting developmental dysplasia of the hip (DDH), reconstructed infant body-surface meshes should preserve the target surface while excluding bed, support, and background geometry. This study proposes a structured vision-language model (VLM)-based multi-view segmentation method for infant phantom mesh cleanup. Text-guided 2D masks provide foreground and background evidence; mask-quality statistics and structured VLM assessments generate view-specific foreground-support weights that undergo deterministic risk suppression before target/non-target classification of 3D vertices. Hard voting and Rule-weighted voting were baselines under identical projection and post-processing settings. We evaluated one physical infant phantom across 150 separate acquisition-reconstruction trials under controlled conditions, each comprising 40 voting views and 10 held-out evaluation views, yielding 1500 manually annotated reference masks. Structured VLM voting achieved a Balanced score (intersection over union minus the 2-pixel tolerant leakage rate) of 0.804 ± 0.085, versus 0.801 ± 0.084 and 0.793 ± 0.086 for Rule-weighted and Hard voting. This leakage rate was 0.087 ± 0.043, versus 0.089 ± 0.042 and 0.092 ± 0.043; mean Coverage remained similar (0.992-0.993). The Balanced-score gain and leakage-rate reduction relative to Rule-weighted voting remained significant after Holm correction (adjusted <i>p</i> = 0.029 and <i>p</i> = 0.033, respectively). Validation using real-infant data, 3D reference standards, and closed-loop robotic scanning is still required.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"13 10","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13701739/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering13101213","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
For robotic ultrasound targeting developmental dysplasia of the hip (DDH), reconstructed infant body-surface meshes should preserve the target surface while excluding bed, support, and background geometry. This study proposes a structured vision-language model (VLM)-based multi-view segmentation method for infant phantom mesh cleanup. Text-guided 2D masks provide foreground and background evidence; mask-quality statistics and structured VLM assessments generate view-specific foreground-support weights that undergo deterministic risk suppression before target/non-target classification of 3D vertices. Hard voting and Rule-weighted voting were baselines under identical projection and post-processing settings. We evaluated one physical infant phantom across 150 separate acquisition-reconstruction trials under controlled conditions, each comprising 40 voting views and 10 held-out evaluation views, yielding 1500 manually annotated reference masks. Structured VLM voting achieved a Balanced score (intersection over union minus the 2-pixel tolerant leakage rate) of 0.804 ± 0.085, versus 0.801 ± 0.084 and 0.793 ± 0.086 for Rule-weighted and Hard voting. This leakage rate was 0.087 ± 0.043, versus 0.089 ± 0.042 and 0.092 ± 0.043; mean Coverage remained similar (0.992-0.993). The Balanced-score gain and leakage-rate reduction relative to Rule-weighted voting remained significant after Holm correction (adjusted p = 0.029 and p = 0.033, respectively). Validation using real-infant data, 3D reference standards, and closed-loop robotic scanning is still required.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering